MENU
+Compare
HRTX
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$2.14
Change
-$0.02 (-0.93%)
Capitalization
326.49M

HRTX Heron Therapeutics Forecast, Technical & Fundamental Analysis

Heron Therapeutics Inc is a commercial-stage biotechnology company... Show more

Industry: #Biotechnology
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HRTX with price predictions
Jun 27, 2025

Momentum Indicator for HRTX turns positive, indicating new upward trend

HRTX saw its Momentum Indicator move above the 0 level on June 20, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for HRTX just turned positive on June 02, 2025. Looking at past instances where HRTX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

HRTX moved above its 50-day moving average on June 23, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HRTX crossed bullishly above the 50-day moving average on June 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where HRTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HRTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HRTX broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HRTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). HRTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.205) is also within normal values, averaging (252.247).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HRTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HRTX is expected to report earnings to fall 233.00% to -1 cents per share on August 12

Heron Therapeutics HRTX Stock Earnings Reports
Q2'25
Est.
$-0.01
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.02
The last earnings report on May 06 showed earnings per share of 0 cents, beating the estimate of -1 cents. With 5.48M shares outstanding, the current market capitalization sits at 326.49M.
A.I. Advisor
published General Information

General Information

a manufacturer of polymer technologies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4242 Campus Point Court
Phone
+1 858 251-4400
Employees
126
Web
https://www.herontx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGFEF3.27N/A
N/A
EUROBANK ERGASIAS SVCS AND HOLDINGS SA
HUBV0.11N/A
N/A
Hubb Ventures Inc.
JNPKF22.25N/A
N/A
Jenoptik AG
HONT117.35N/A
N/A
Honat Bancorp, Inc.
DSNKY22.88-0.08
-0.35%
Daiichi Sankyo Co., Ltd.

HRTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with ABOS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-0.93%
ABOS - HRTX
39%
Loosely correlated
-7.44%
ACAD - HRTX
39%
Loosely correlated
-0.41%
ARDX - HRTX
38%
Loosely correlated
+0.14%
ABSI - HRTX
37%
Loosely correlated
-3.32%
RNAC - HRTX
36%
Loosely correlated
-6.81%
More